logo
Proposed bill would trim training hours for barbers and cosmetologists

Proposed bill would trim training hours for barbers and cosmetologists

Yahoo27-02-2025

SALT LAKE CITY () — Senate Bill 330 advanced from the Business and Labor Committee Wednesday by a vote of 5-1. The bill amends the requirements to get a license as a barber or cosmetologist.
The , sponsored by Sen. Scott Sandall (R), would also create micro-licenses or permits. This would allow people who are interested in a specific field to specialize and not go through full training.
For example, to get a license as a master esthetician, it would require 1,200 training hours. But if you're only interested in doing nails, that would take 300 hours. Eyebrows? Just 270 hours.
Supporters say it helps more people get into the business while saving on time and money.
Stylist Rhonda Halliday likes that idea, saying, 'The micro-licensing and the letting students have access to these programs without having to go through only beauty schools to get them.'
Barbers, however, say that dropping their hours from 1,000 to a 130 training hour permit doesn't make the cut.
Richard Hite owns The Barber School in Midvale and completely opposes the idea of a barber getting a permit after 130 hours.
He explained, 'These are craftsmen. These people are highly skilled people that provide a craft that can't be duplicated by a stupid certificate for 130 hours.'
Hite also believes the shorter hours would be bad for business. He claims that while it would open the door to more barbers, it would also open it to bad quality.
'The public eventually is going to say, 'Hey, I'm not getting a consistent haircut. I'm out of here. I'm going to go somewhere else,'' Hite said. 'So, the barber is no longer able to hire people because there's no qualified people out there in the pool to be hired.'
Jeff Shumway, the director of the Office of Professional Licensure Review, says the office would have supported even lower hours. He says they arrived at these hours by studying health professionals and the requirements they meet in certain training. They believe the license is issued to make sure standards of health and safety are met — not whether or not your barber can line you up correctly or perfect a fade.
'It doesn't necessarily say you're going to get, you know, exactly the haircut you want, but it's going to be safe. You're not going to get sick. You're not going to get hurt,' Shumway explained.
Hite and other barbers in attendance disagree. Dave Broderick, a local barber, referenced his ability to detect worrisome issues with his clients' skin. He mentioned two instances where he referred clients to dermatologists, and they found cancer — something he says his experience and training enable him to spot out.
Hite says 130 hours just isn't enough. 'It just satisfies that you've seen the words 'health and safety' somewhere, maybe in a book, and that you're no longer a health risk to the public. That's all that they care about.'
Sen. Sandall admits the bill's current form isn't perfect. In fact, he has 22 changes (and counting) that he wants to make in a substitute bill based on the feedback he received. Committee Chair Evan Vickers was the lone vote against the bill, citing it not being done as his reason. He pledged to help make sure the bill addresses the concerns as it moves through the process.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors

Yahoo

time4 days ago

  • Yahoo

Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors

BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions, today announced the appointments of Adam Koppel and Christopher Hite to its Board of Directors. 'We are thrilled to welcome Adam and Chris to our Board of Directors. Their extensive track records as respected advisors to biopharma companies on corporate and financial strategy will be incredibly valuable as we continue to execute on our mission to advance next-generation therapies for the treatment of obesity,' said Ron Renaud, President and Chief Executive Officer, Kailera. 'It's an exciting time to join Kailera's Board as they progress their pipeline toward late-stage global trials, and I look forward to contributing to the company's continued success and long-term value creation,' said Dr. Koppel. Mr. Hite added, 'I am pleased to join the Board of Kailera at this important time of innovation in the obesity space that has positively impacted millions of patients worldwide. Kailera has a clear strategy to advance their diversified pipeline, and I look forward to supporting the leadership team as they work towards achieving their mission.' Dr. Koppel is a distinguished investor and strategic leader with more than 25 years of biopharmaceutical industry experience. He is a Partner on Bain Capital's Life Sciences team and initially joined Bain Capital in 2003. Previously, Dr. Koppel was EVP of Corporate Development and Chief Strategy Officer at Biogen. He currently sits on the Board of Directors of Areteia Therapeutics and Cardurion Pharmaceuticals and serves on the Board of Trustees at Newton Wellesley Hospital. Dr. Koppel also co-chairs the Harvard Medical School Discovery Council and serves on the Mass General Brigham Innovation Growth Board. He received an M.D. and Ph.D. in Neuroscience from the University of Pennsylvania School of Medicine. Dr. Koppel also received an M.B.A. from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar, and graduated magna cum laude from Harvard University with an A.B. and A.M. in History and Science. Mr. Hite, a seasoned financial executive with over 25 years of financial and strategic experience in the biopharmaceutical industry, will serve as an independent board member and audit committee chair. Mr. Hite currently serves as Executive Vice President and Vice Chairman at Royalty Pharma. Prior to joining Royalty Pharma in 2020, he was at Citibank for over a decade, serving most recently as Vice Chairman of Banking, Capital Markets and Advisory (BCMA) and a member of the BCMA Executive Committee, and previously as the Global Head of Healthcare Investment Banking. Prior to joining Citibank, Mr. Hite was the Global Head of Healthcare Investment Banking at Lehman Brothers. He serves on the Board of Trustees at Lehigh University, the Board of Advisors of Faster Cures, a center of the Milken Institute, and served on the Board of Directors of Acceleron Pharma Inc. until its acquisition by Merck in November 2021. Mr. Hite has a B.S. from Lehigh University, and a J.D. and M.B.A. from the University of Pittsburgh. About Kailera Therapeutics Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity and related conditions. Kailera's most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that has demonstrated positive results in Phase 2 trials in obesity and type 2 diabetes in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery, including oral administration. Kailera's mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit and follow us on LinkedIn and X. Contact Information Maura Gavaghan Vice President, Corporate Communications and Investor Relations while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Travel sector ‘walks a tight rope' as US hotel growth outlook downgraded: report
Travel sector ‘walks a tight rope' as US hotel growth outlook downgraded: report

Yahoo

time6 days ago

  • Yahoo

Travel sector ‘walks a tight rope' as US hotel growth outlook downgraded: report

This story was originally published on Hotel Dive. To receive daily news and insights, subscribe to our free daily Hotel Dive newsletter. At the NYU International Hospitality Investment Forum Monday, CoStar and Tourism Economics downgraded their 2025 and 2026 growth projections for U.S. hotel top-line performance metrics, including RevRAR, citing elevated macroeconomic concerns. The companies now forecast that U.S. hotel RevPAR and ADR will grow 1% and 1.3% year over year, respectively, in 2025, down from their previous January projections of 1.8% and 1.6% year-on-year growth. The companies also lowered their RevPAR and ADR growth guidance for 2026 and downgraded occupancy, supply and demand projections for both years as well. The downgrades come as economic uncertainty mounts following President Donald Trump's tariff announcements and other recent government actions. Aran Ryan, director of industry studies at Tourism Economics, said that the economy — and the travel sector — will 'walk on a tight rope' through the second half of this year. Though 'recession risks have eased,' according to Ryan, CoStar and TE downgraded their 2025 and 2026 growth projections for all measured top-line hotel performance metrics on the heels of underperformance in the first quarter of the year. In addition to lowering growth guidance on RevPAR and ADR, the companies now project that occupancy will sit at 62.8% in 2025, down from their January forecast of 63.1%. The companies forecast 0.8% and 0.5% year-over-year growth for supply and demand in 2025, respectively, down from their previous projections of 0.9% and 1.1% growth. The downgrades come amid 'consumers facing higher prices and a weaker labor market, businesses tapping the brakes on investment, and soft international visitor volumes,' Ryan said in a Monday statement. Hotel CEOs noted shifts in traveler demand and booking behavior during Q1 earnings calls, with several companies — including Marriott International, Hyatt Hotels, Choice Hotels International and Wyndham Hotels & Resorts — similarly downgrading 2025 RevPAR guidance, citing ongoing economic uncertainty. Recent Trump administration actions are slated to have a downward impact on corporate travel and international visitor spending as well, per recent reports from the Global Business Travel Association and the World Travel & Tourism Council. Until consumer confidence improves, 'demand is going to remain softer — especially in the middle and lower price tiers,' Amanda Hite, president of CoStar-owned STR, said in a Monday statement. 'Rate is pushing the top line in the group segment, and business transient should continue to recover in a lot of industries, but leisure gains are going to be more isolated,' she said. Hite also noted that booking windows have shortened, which 'adds to the challenges hoteliers will face in the coming quarters.' Onstage at NYU IHIF, Hite shared that bookings for July and August are down from last year. 'This is not something we're raising a big red flag about right now,' she said. 'This is more a highlight of that shortened booking window.' However, it isn't all bad news for hotels. 'The headlines make it seem like things are falling off the cliff,' Hite said Monday. 'But we do have demand growing.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bill weakening Nebraska paid sick leave passes, but Dems stall effort to slow minimum wage growth
Bill weakening Nebraska paid sick leave passes, but Dems stall effort to slow minimum wage growth

Yahoo

time29-05-2025

  • Yahoo

Bill weakening Nebraska paid sick leave passes, but Dems stall effort to slow minimum wage growth

State Sen. Jane Raybould of Lincoln, center, talks with State Sens. Paul Strommen of Sidney and Kathleen Kauth of the Millard area on May 28, 2025. Raybould sponsored a measure to slow voter-approved minimum wage increases while Strommen sponsored a measure to weaken voter-approved paid sick leave. Kauth chairs the Legislature's Business and Labor Committee. (Zach Wendling/Nebraska Examiner) LINCOLN — A majority of Nebraska Democrats and one Republican in the officially nonpartisan Legislature successfully blocked an attempt to add a proposal to slow the state's voter-approved minimum wage increases to a bill weakening voter-passed paid sick leave. State Sen. Jane Raybould filed her once-defeated minimum wage proposal as an amendment to Lincoln State Sen. Beau Ballard's Legislative Bill 415 after Speaker John Arch decided not to reschedule her stand-alone bill due to time constraints. Lawmakers were unable to consider the amendment — which was likely to pass — because Democratic-aligned lawmakers had already filed several motions to filibuster Ballard's original proposal. Raybould said her reason for wanting to act now had to do with the political dynamics facing her bill if the lawmakers wait. She said it would be harder to reduce pay for young people after the fact. Raybould's revived proposal, in its current form, would shrink the wage increases by setting the annual increase at 1.75%. It also would create a youth minimum wage and amend a separate state training wage. Raybould and supporters of her measure said her changes would protect small businesses that could not afford to pay more. Lawmakers against the legislative effort to slow wage growth said they were defending the people's will. 'Despite continued efforts to walk back the voice of the people, I'm glad that we were at least able to fight for everyday working Nebraskans by stopping this attack on minimum wage.' State Sen. George Dungan of Lincoln said after the vote. Raybould pushed back by saying Nebraska lawmakers aren't trying to undermine what voters approved the way Missouri and some other state Legislatures have done in recent months. Missouri recently repealed a paid sick leave law that voters approved just months before. 'We care about our working families,' Raybould said during the LB 415 debate. 'These two bills help our Nebraska families.' Worker advocates and union leaders have spoken out against the paid sick leave and mimmutin wage changes as attempts to undermine voters. Ballard had previously said he didn't consider Raybould's amendment unfriendly and would have supported it. 'It was worth a swing,' Ballard told the Examiner. Even though Democratic-aligned lawmakers blocked Raybould's amendment from being considered the GOP majority passed Ballard's proposal 33-15. It adds new restrictions to the paid sick leave law Nebraska voters approved last year, which has yet to be implemented. LB 415 would remove the voter-approved law's blanket sick leave requirements, letting employers offer no paid sick leave to young teens, ages 14 and 15, and none to temporary workers, seasonal agricultural workers and workers at the state's smallest businesses, those with 10 or fewer employees. Ballard said the proposal intends to clarify and make the ballot measure 'more feasible' and workable for businesses. Passage of LB 415 is the latest part of a trend of the GOP-led Legislature pushing back against a handful of ballot measures passed by Nebraska voters. Targets this year include voter efforts to require paid sick leave, raise the minimum wage, repeal school vouchers and legalize and regulate medical marijuana. Raybould's stand-alone bill will most likely be voted on next session. Though highly unlikely, Arch could change his mind about scheduling it. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store